109966-30-5

Basic information

• Product Name: 6-BENZYL-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE
• Synonyms: 6-BENZYL-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE;6-benzyl-5H,6H,7H-pyrrolo[3,4-b]pyridine
• CAS NO: 109966-30-5
• Molecular Formula: C₁₄H₁₄N₂
• Molecular Weight: 210.27
• Product Categories: pharmacetical;Heterocycle-Pyridine series
• Mol File: 109966-30-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 313.094 °C at 760 mmHg
• Flash Point: 143.155 °C
• Appearance: /
• Density: 1.161 g/cm³
• Vapor Pressure: 0.000507mmHg at 25°C
• Refractive Index: 1.632
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 6.08±0.20(Predicted)
• CAS DataBase Reference: 6-BENZYL-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BENZYL-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE(109966-30-5)
• EPA Substance Registry System: 6-BENZYL-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE(109966-30-5)

Safety Data

• Hazardous Substances Data: 109966-30-5(Hazardous Substances Data)

Usage

Uses

6-Benzyl-6,7-dihydro-5h-pyrrolo[3,4-b]pyridine is used as a reactant in the synthesis of substituted isoindolines as inhibitors of DPP8/9.

InChI:InChI=1/C14H14N2/c1-2-5-12(6-3-1)9-16-10-13-7-4-8-15-14(13)11-16/h1-8H,9-11H2

Upstream product

• 1046121-24-7 6-benzyl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-7-one 
• 18184-75-3 6-benzyl-5H-pyrrolo[3,4-b]pyridine-5,7(6H)-dione 

Downstream Products

• 1059172-92-7 tert-butyl 5H-pyrrolo[3,4-b]pyridine-6(7H)-carboxylate 
• 147739-88-6 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine 

Relevant articles and documents

CYCLOBUTENEDIONE DERIVATIVES

The present invention relates to compounds of the formula (I): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly inflammatory conditions.

1, 2, 4 -TRIAZOLE DERIVATIVES AS VASOPRESSIN ANTAGONISTS

Compounds of formula (I), or a pharmaceutically acceptable salt, solvate, ester or amide thereof, wherein R1 represents [CH2]n-R2; R2 represents H, C1-6 alkyloxy or Het; n represents a numb